Fixal

Quick links to important sections

Fixal

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fixal

What is Fixal? (Overview and Quick Facts)

Property Description
Active ingredient Fexofenadine (INN)
Primary Form Tablet and Oral Suspension
Pharmacological class H1-Receptor Antagonist
Common Use Relief of Allergic Symptoms
Origin Synthetic, Second-Generation Compound

What Type of Medicine is Fixal? Defining the Entity

Fixal is a medicinal preparation whose sole active ingredient is Fexofenadine, classifying it as a second-generation antihistamine. This medicine belongs to the pharmacological class of non-sedating H1-receptor antagonists, which defines its mechanism for managing allergic responses. Fexofenadine is chemically categorized as a synthetic piperidine derivative and serves as the pharmacologically active metabolite of the older antihistamine, terfenadine. Its status as a second-generation compound is defined by its high selectivity for peripheral receptors. This structural distinction makes the compound a primary agent in the management of allergic conditions, available in both over-the-counter (OTC) and prescription formats depending on formulation strength and regional availability.

Fexofenadine: Composition and Available Forms

The preparation Fixal is a single active ingredient product, consisting of Fexofenadine combined with pharmaceutical excipients. It is routinely supplied in two primary drug forms suitable for the oral route of administration: a solid tablet and a liquid oral suspension. The availability of both forms, particularly the oral suspension, is intended to accommodate diverse patient groups, including pediatric patients, who may require alternatives to the standard tablet for easier consumption. The liquid form allows for dosing flexibility and is typically formulated with flavoring to aid administration in children.

What is the General Purpose of This Antihistamine?

The general purpose of Fixal is to provide symptomatic relief during various allergic conditions by managing the effects of histamine-mediated symptoms. The medicine functions through the selective antagonism of peripheral histamine H1-receptors, preventing histamine—a substance released during an allergic response—from binding to these receptors. This mechanism ensures the preparation serves to counter the physiological process of the allergic reaction, offering relief from common allergic discomforts, such as those experienced during seasonal increases in pollen exposure.

Regulatory References

  1. Fexofenadine (NIH DailyMed)
  2. Fexofenadine (NIH MedlinePlus Drug Information)

What side effects are possible with Fixal?

Possible Side Effects and Safety Information

The officially documented adverse effects for Fixal (fexofenadine) are classified based on frequency as reported in regulatory documents like the Summary of Product Characteristics (SmPC) and FDA labeling. Adverse reactions are grouped by the System-Organ Class (SOC) they affect, maintaining regulatory terminology.


Adverse Reactions by Official Frequency Classification

Frequency Tier Example Adverse Reactions System-Organ Class Involved
Common (ge 1/100 to < 1/10) Headache, Drowsiness, Dizziness, Nausea Nervous System, Gastrointestinal
Uncommon (ge 1/1,000 to < 1/100) Fatigue General Disorders
Not Known (Post-Marketing) Insomnia, Palpitations, Hypersensitivity reactions, Rash, Urticaria Psychiatric, Cardiac, Immune System, Skin

Serious Adverse Reactions and Safety Cautions

The safety profile includes rare, but clinically significant, reactions documented primarily through post-marketing surveillance. These include severe Hypersensitivity reactions, such as Systemic anaphylaxis, Angioedema, Dyspnoea, and Chest tightness.

Regulatory documents advise specific caution for certain populations. This medicine should be administered with care to older adults and to patients with existing renal impairment or hepatic impairment due to potential alterations in the body's processing of the medication. Additionally, caution is advised for individuals with a history of cardiovascular disease regarding the potential for tachycardia and palpitations.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Official regulatory documentation on Fixal (Fexofenadine) indicates that reports of overdose are infrequent and contain limited clinical information.

Documented Overdose Manifestations

Overdose presentations reported in official documents are generally limited to non-severe, transient clinical signs and symptoms. These include:

  • Drowsiness
  • Dizziness
  • Dry mouth

No specific severe or life-threatening outcomes are explicitly documented within the official overdose section of major regulatory prescribing information.

Required Emergency Actions and Management

When an overdose occurs, regulatory guidance requires immediate action focused on supportive care and reducing absorption of the drug.

Management Requirement Official Statement
Help-Seeking Action Seek immediate medical attention or get medical help. Contact a Poison Control Center.
Urgent Medical Help Call emergency services (911) if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.
Supportive Treatment Treatment should be symptomatic and supportive, including considering standard measures to remove any unabsorbed drug.
Antidote Availability No specific antidote is documented or listed in the official regulatory prescribing information.

The official profile mandates seeking professional medical assistance for any suspected overdose and clearly defines the critical, life-threatening conditions under which emergency services must be contacted.

Therapeutic Uses of Fixal

What Fixal Treats: Main Uses and Benefits

Fixal is used across therapeutic domains to relieve symptoms associated with histamine-mediated allergic conditions.

Fixal is commonly used across conditions presenting with acute episodes and characterized by periods of heightened symptoms, notably seasonal and perennial allergic rhinitis and Chronic Idiopathic Urticaria (Hives). The medicine helps address symptom clusters that may become intense or disruptive, specifically targeting sneezing, runny nose, itchy eyes, watering eyes (lacrimation), and pronounced dermatologic manifestations like intense itching (pruritus) and red, raised wheals.

The core benefit is supportive symptom management, relevant in contexts involving heightened systemic burden. Fixal contributes to maintaining a sense of stability when symptoms are more noticeable, providing a non-sedating form of relief that helps patients cope more steadily with difficult, recurrent episodes.


Quick Fact: Relief for Functional Strain
Primary Symptom Domains: Upper respiratory, ocular, and dermatologic discomfort.
Core Benefit: Provides non-sedating relief that supports functional stability.
Typical Context: Used during periods of heightened symptom intensity (seasonal or chronic).

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Fixal?

Fixal (Fexofenadine) eligibility is strictly defined by regulatory documents, establishing who is permitted to use the medicine and who must not.

Eligibility Status

Category Regulatory Status Status Detail
Absolute Contraindication Prohibited Patients with known hypersensitivity (allergy) to fexofenadine or any inactive ingredients in the formulation.
Standard Approval Permitted Adults and adolescents (12 years and older). Children are approved down to 6 months (for oral suspension forms, depending on the indication).
Conditional Use Caution Required Patients with impaired renal function (kidney disease) require dose selection with caution, as the drug is mainly eliminated by the kidneys. Older adults (65 years and older) require caution due to potential age-related decreased renal function.
Pregnancy and Lactation Restricted Use in pregnancy is advised only if the potential benefit justifies the potential risk to the fetus. Use is not recommended in women who are breastfeeding.

Use Not Established

Regulatory agencies confirm that safety and efficacy have not been established in infants younger than 6 months of age. Additionally, individuals with Phenylketonuria (PKU) should exercise caution with oral disintegrating tablets, as they may contain phenylalanine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Fixal interactions is strictly defined by two types of pharmacokinetic interference that alter the drug's systemic exposure. Fixal undergoes minimal metabolism, and clinically significant drug-drug interactions are primarily transporter-mediated or involve binding within the gastrointestinal tract.

Interaction Type Interacting Substance Official Regulatory Outcome
Exposure Increase Ketoconazole (Antifungal) Significant increase in systemic exposure (AUC mathbf+164%) and peak plasma concentration (Cmax mathbf+135%) due to transport-related effects.
Exposure Increase Erythromycin (Antibiotic) Significant increase in systemic exposure (AUC mathbf+109%) and peak plasma concentration (Cmax mathbf+82%) due to transport-related effects.
Exposure Reduction Antacids (Aluminum/Magnesium) mathbfTiming rule: Administration must be separated by mathbf15 minutes to prevent a reduction in bioavailability (up to 43% Cmax decrease) from GI binding.
Food Interaction Fruit Juices (Apple, Orange, Grapefruit) Restricted from co-administration as they are documented to reduce bioavailability by inhibiting intestinal uptake transporters.

These administration constraints are established to ensure consistent drug absorption. Additionally, official labeling notes that patients with renal impairment are documented to experience increased systemic exposure because the drug's oral clearance is decreased due to slower removal from the body.

Mechanism of Action

How Fixal Works: Mechanism of Action

Fixal exerts its action through the selective modulation of key regulatory receptors within the central and/or peripheral signaling systems. The drug acts as a high-affinity modulator at the receptor site, adjusting the receptor's sensitivity and responsiveness. This interaction primarily influences signaling that characterizes processes of heightened activity.

This initial engagement triggers a subsequent alteration in intracellular signal transduction. Fixal modifies early molecular steps within the targeted mechanistic cascades, initiating or suppressing specific signaling sequences that lead to downstream effects. This mechanism acts to modify the effects of excessive mediator activity by influencing the flow of internal cellular communication.

Ultimately, the combined molecular and cellular effects result in the regulation of processes driven by distinct signaling patterns. This mechanistic domain affects the signaling patterns of heightened physiological responses, influencing activity toward a modified steady state within the targeted pathways, and resulting in system-wide physiological adjustments.

Dosage and Administration Information

Fixal is administered via the oral route, available in both tablet and oral suspension dosage forms. Standard adult regimens for approved indications are typically 180 mg taken once daily or 60 mg taken twice daily, reflecting its use as a consistent daily treatment. The maximum recommended dose for adults is 180 mg per day.


Contextual Intake Rules

For proper administration, tablets should be swallowed whole with water. A primary instruction is to avoid administering the medicine with fruit juices (including apple, orange, and grapefruit) as these beverages can interfere with absorption. If using the liquid oral suspension, the container requires shaking well before the required dose is measured. Furthermore, the medicine should be taken separately from antacids containing aluminum or magnesium hydroxide, as simultaneous intake is not recommended.


Population-Specific Use

Dose adjustments are specified for certain groups. Adults with renal impairment (reduced kidney function) are designated to receive a lower initial dose, typically 60 mg once daily. For pediatric patients aged 6 to 11 years, the standard dose is 30 mg twice daily. If a dose is missed, it is advised to resume the normal schedule at the next designated time and not to double the dose.

Recent Clinical Evidence

Fixal is the brand name for fexofenadine, a second-generation, non-sedating antihistamine studied for its role in managing symptoms of allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives).


Efficacy and Symptom Relief

Clinical studies, including double-blind, placebo-controlled trials, indicate that the administration of Fixal is associated with a reduction in physical symptoms linked to allergic conditions. These symptoms include sneezing, rhinorrhea (runny nose), lacrimation (watery eyes), and pruritus (itching) of the nose, throat, or skin. In studies on chronic idiopathic urticaria, the use of Fixal was associated with a reduction in the number of wheals and the severity of itching.

Tolerability and Safety Profile

As a peripheral H1 receptor antagonist, Fixal is designed to minimally cross the blood-brain barrier. This feature is studied to correlate with a lower potential for central nervous system (CNS) effects, such as drowsiness, compared to first-generation antihistamines. In clinical trials, the incidence of reported adverse events such as headache, nausea, and dizziness was generally comparable to that observed in the placebo groups.

Pharmacological Studies

Research indicates that Fixal is associated with rapid absorption following oral administration, with peak plasma concentrations typically achieved within two to three hours. It undergoes minimal hepatic metabolism and is primarily eliminated unchanged. Studies examining potential drug-drug interactions suggest that the co-administration of Fixal with certain inhibitors (such as erythromycin or ketoconazole) may lead to increased plasma levels of fexofenadine, though this effect has not been associated with significant adverse cardiac or sedative effects in clinical trials.

Frequently Asked Questions (FAQ)

Common questions about Fixal (FAQ)


Q: How quickly can someone expect Fixal to start working?

Studies and official information indicate that Fixal is rapidly absorbed following oral use. The medicine's concentration is reported to peak in the blood within approximately two to three hours following administration.


Q: Is it possible for Fixal to affect my sleep?

Regulatory reports show that Fixal may potentially affect sleep in different ways. Drowsiness is described as a common effect in official labeling. Additionally, post-marketing reports have included instances of insomnia (difficulty sleeping) but with an unknown frequency.


Q: Are there any specific foods I should avoid while using Fixal?

Yes, official instructions advise against administering the medicine with fruit juices. Beverages such as apple, orange, or grapefruit juice are documented in regulatory sources to interfere with how the drug is absorbed by the body.


Q: Can people with certain chronic health conditions use Fixal?

Official labeling advises that the use of Fixal requires caution for patients with certain pre-existing chronic health conditions. These groups, as specified in regulatory information, include those with renal impairment (reduced kidney function), hepatic impairment (liver disease), and a history of cardiovascular disease.


Q: Is it common to feel a difference in the first few days of using Fixal?

Clinical studies show that the medicine is associated with rapid absorption, with peak levels in the body typically achieved within a few hours. Efficacy trials demonstrated that the administration of Fixal is associated with a reduction in physical symptoms linked to allergic conditions.


Q: Why are people with liver problems advised to be cautious with Fixal?

Caution is advised for those with hepatic impairment (liver disease) because the drug is processed with minimal metabolism in the liver. This limited metabolism means that dose adjustments may be mandated by a healthcare provider.


Q: Can I use Fixal if I have allergies to other medications?

According to the official product information, the only absolute contraindication (prohibited use) is a known hypersensitivity (allergy) to fexofenadine, the active ingredient, or to any of the inactive ingredients in the formulation.


Q: What does the research say about Fixal's effectiveness in older adults?

Specific efficacy data focusing solely on the elderly is generally not separately detailed in official documents; however, official caution is advised for older adults (65 years and older). This is due to the potential for age-related decreased renal function, which can influence the medicine's systemic exposure.


Q: How does Fixal differ from other drugs that treat similar conditions?

Fixal is defined as a second-generation antihistamine. It is designed to minimally cross the blood-brain barrier, a feature associated with a reduced likelihood of central nervous system (CNS) effects, such as drowsiness.


Q: What is the purpose of the different strengths Fixal is available in?

The availability of different strengths is necessary to accommodate varied approved indications and to allow for necessary dose adjustments. Official instructions outline specific doses required for certain patient groups, such as those with renal impairment or pediatric patients.


Q: What is the general patient experience with the taste or texture of Fixal?

Official documents note that Fixal is available in both a tablet and a liquid form. The liquid oral suspension is typically formulated with simple flavoring to aid administration, particularly for children.


Q: Can I crush or split Fixal tablets?

The official administration instructions for Fixal tablets state that they should be swallowed whole with water. The official instructions advise swallowing the tablet whole, and do not provide information on crushing or splitting.


Q: What are the known potential interactions between Fixal and alcohol?

Regulatory documents state that Fixal does not appear to potentiate the effects of alcohol. However, in general patient counseling, the general caution is that alcohol in excess is typically advised against.


Q: Are there any warnings about using Fixal while operating machinery?

Official labeling states that although studies show no effect on the ability to drive or use machines, patients are advised to observe their individual response to the medication before driving or operating machinery. This is due to the possibility of drowsiness or dizziness in some individuals.


Q: What is the significance of the Fixal 'Prescribing Information' document?

The Prescribing Information is the official, government-approved regulatory source for the drug. It contains all the mandatory information about the drug's approved uses, safety profile, recommended dosing, and known interactions.


Q: Are there long-term safety data available for Fixal?

Regulatory reviews acknowledge the availability of extensive safety data for Fixal. This data includes studies that assessed the long-term safety performance of fexofenadine for up to one year at high doses in healthy subjects.

How should Fixal be stored and disposed of?

Fixal (fexofenadine hydrochloride) must be stored strictly according to regulatory guidelines to maintain its stability and effectiveness.


Storage Conditions

Fixal should be stored at Controlled Room Temperature, which is between 20^circ to 25 C (68^circ to 77 F). The medicine must be protected from excessive moisture and should be kept from freezing. Tablets must remain in their original packaging and should not be used if the safety seal or blister units are torn.


Disposal and Safety

It is a mandatory storage requirement that Fixal be kept out of the reach and sight of children. For disposal of unused or expired medicine, patients should ask a pharmacist or healthcare professional for guidance. Official instructions advise against throwing medicines away via wastewater or household waste to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fixal found in:

A-Z Index: